A decreased serum leptin level in patients with systemic sclerosis

Clinical Rheumatology

Volumn 20, Issue 4, 2001, Pages 300-302

  Kotulska, A ^a   Kucharz, E J ^a   Brzezinska Wcislo L ^a   Wadas, U ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Leptin; Systemic sclerosis

Indexed keywords

LEPTIN;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ADULT; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEPTIN; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; PROBABILITY; PROGNOSIS; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0034893068     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670170053     Document Type: Article

References (8)

1. Systemic sclerosis (scleroderma): Clinical aspects
2. Thyroid disorders in patients with progressive systemic sclerosis
3. Leptin
4. Leptin in human plasma is derived in part from the brain, and cleared by the kidney
5. The stomach is a source of leptin
6. Estrogen increases in vivo leptin production in rats and human subjects
7. Role of the kidney in human leptin metabolism
8. Gastric emptying in patients with progressive systemic sclerosis; in Polish